Annual Total Liabilities
$19.37 M
+$7.46 M+62.61%
31 December 2023
Summary:
Eupraxia Pharmaceuticals Common Stock annual total liabilities is currently $19.37 million, with the most recent change of +$7.46 million (+62.61%) on 31 December 2023. During the last 3 years, it has risen by +$1.25 million (+6.87%). EPRX annual total liabilities is now at all-time high.EPRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.39 M
-$9.25 M-79.49%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock quarterly total liabilities is currently $2.39 million, with the most recent change of -$9.25 million (-79.49%) on 01 September 2024. Over the past year, it has dropped by -$11.80 million (-83.18%). EPRX quarterly total liabilities is now -87.68% below its all-time high of $19.37 million, reached on 31 December 2023.EPRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.6% | -83.2% |
| 3 y3 years | +6.9% | -74.8% |
| 5 y5 years | +84.0% | - |
EPRX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +111.7% | -87.7% | at low |
| 5 y | 5 years | at high | +111.7% | -87.7% | at low |
| alltime | all time | at high | +3211.2% | -87.7% | at low |
Eupraxia Pharmaceuticals Common Stock Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.39 M(-79.5%) |
| June 2024 | - | $11.64 M(-37.2%) |
| Mar 2024 | - | $18.53 M(-4.4%) |
| Dec 2023 | $19.37 M(+62.6%) | $19.37 M(+36.5%) |
| Sept 2023 | - | $14.19 M(+28.3%) |
| June 2023 | - | $11.06 M(-7.2%) |
| Dec 2022 | $11.91 M | - |
| Dec 2022 | - | $11.91 M(+31.7%) |
| Sept 2022 | - | $9.05 M(-13.3%) |
| June 2022 | - | $10.44 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.71 M(-4.8%) |
| Dec 2021 | $9.15 M(-49.5%) | $9.15 M(-3.3%) |
| Sept 2021 | - | $9.47 M(+22.2%) |
| June 2021 | - | $7.74 M(+24.6%) |
| Mar 2021 | - | $6.21 M(-65.7%) |
| Dec 2020 | $18.13 M(+10.6%) | $18.13 M(+6.6%) |
| Sept 2020 | - | $17.00 M(+3.7%) |
| Dec 2019 | $16.39 M(+55.7%) | $16.39 M |
| Dec 2018 | $10.53 M(+1700.0%) | - |
| Dec 2017 | $585.10 K | - |
FAQ
- What is Eupraxia Pharmaceuticals Common Stock annual total liabilities?
- What is the all time high annual total liabilities for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock annual total liabilities year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock quarterly total liabilities?
- What is the all time high quarterly total liabilities for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock quarterly total liabilities year-on-year change?
What is Eupraxia Pharmaceuticals Common Stock annual total liabilities?
The current annual total liabilities of EPRX is $19.37 M
What is the all time high annual total liabilities for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high annual total liabilities is $19.37 M
What is Eupraxia Pharmaceuticals Common Stock annual total liabilities year-on-year change?
Over the past year, EPRX annual total liabilities has changed by +$7.46 M (+62.61%)
What is Eupraxia Pharmaceuticals Common Stock quarterly total liabilities?
The current quarterly total liabilities of EPRX is $2.39 M
What is the all time high quarterly total liabilities for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high quarterly total liabilities is $19.37 M
What is Eupraxia Pharmaceuticals Common Stock quarterly total liabilities year-on-year change?
Over the past year, EPRX quarterly total liabilities has changed by -$11.80 M (-83.18%)